在21世纪解决心力衰竭问题
1Johns Hopkins Medical Institutions, 720 Rutland Avenue, Ross 835, Baltimore, Maryland 21205, USA.
Nature
|February 22, 2008
概括
心力衰竭是一种严重的疾病,心脏不能足够的血液. 尽管取得了进展,但它仍然是主要的死亡原因,特别是在老龄化人口中,需要新的治疗方法.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 老年学是一门学科.
背景情况:
- 心力衰竭 (HF),或充血性心力衰竭,损害了心脏提供足够血液流动的能力.
- 这会导致严重的症状,如疲劳和喘息,往往导致死亡.
- 慢性HF是致病率和死亡率的重要原因,在老年人群中患病率越来越高.
研究的目的:
- 审查了解心力衰竭的进展情况.
- 突出需要新的治疗策略的需要.
- 为了应对日益增长的心力衰竭负担在老龄化人口中.
主要方法:
- 对心力衰竭中的分子和细胞过程的审查.
- 分析当前的治疗进展.
- 检查心力衰竭的流行病学趋势.
主要成果:
- 在了解心力衰竭机制方面取得了重大进展.
- 已经开发出有效的治疗方法,但慢性HF仍然是一个主要的健康问题.
- 由于全球人口老龄化,心力衰竭的发病率正在增加.
结论:
- 尽管有治疗方面的进步,慢性心力衰竭仍然是一个关键的健康挑战.
- 针对细胞和器官水平机制的新疗法是必不可少的.
- 考虑到心力衰竭在老年人群中日益流行,解决心力衰竭至关重要.
相关概念视频
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
